Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 5, Issue 4, Pages 287-300Publisher
IOS PRESS
DOI: 10.3233/JAD-2003-5404
Keywords
Reactive oxygen species; Ginkgo biloba; Amyloid beta; Alzheimer's disease; Caenorhabditis elegans
Categories
Funding
- National Institutes of Health/National Center for Complementary and Alternative Medicine [AT00293-01A2]
Ask authors/readers for more resources
The role of amyloid beta-peptide (A beta) in the free-radical oxidative-stress model of neurotoxicity in Alzheimer's disease (AD) has received much attention recently. In this study, we have employed both in vitro and in vivo models displaying endogenous A beta production to study the effects of A beta on intracellular free radical levels. We employed a neuroblastoma cell line stably expressing an AD-associated double mutation, which exhibits both increased secretion and intracellular accumulation of A beta when stimulated, as well as transgenic Caenorhabditis elegans constitutively expressing human A beta. A rise in levels of hydrogen peroxide (H2O2) was observed in both in vitro and in vivo AD-associated transgenic models expressing the A beta peptide compared with the wild type controls. Treatment of the cells or C. elegans with Ginkgo biloba extract EGb 761 significantly attenuated the basal as well as the induced levels of H2O2-related reactive oxygen species (ROS). Among individual EGb 761 components tested, kaempferol and quercetin provided maximum attenuation in both models. Furthermore, an age-dependent increase in H2O2-related ROS was observed in wild type C. elegans, which is accelerated in the AD-associated C. elegans mutant. These results support the hypothesis of the involvement of A beta and ROS in association with AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available